Wednesday, September 16, 2026Latest filing Sep 14, 2026

RARE Congressional Stock Trades

Ultragenyx Pharmaceutical Inc. - Common Stock (RARE)

Last disclosed trade Jul 15

Every disclosed trade in RARE by members of Congress under the STOCK Act, parsed by Coldpine. Informational only, sourced from public filings. Not investment advice.

Sample · the intelligence layer

Coldpine signal scoreA 0-1 composite from four weighted factors: disclosure speed, trade size, cluster activity (multiple members buying the same name), and the member’s track record. ≥ 0.65 is the high-conviction tier; ≥ 0.50 is moderate. Trades from trust-managed members are penalized (× 0.2 multiplier). It’s research, not a recommendation.

Gilbert Cisneros · Bought $RARE · Jul 15 · $1K–$15K

0.34LOW
Disclosure speedx 0.250.10
Trade sizex 0.250.20
Cluster activityx 0.150.00
Track recordx 0.350.76

Every disclosed trade in the database gets this treatment: a four-factor score and a written read from Coldpine’s AI-based analysis. Informational only, not investment advice. Create a free account for every scored trade →

Follow $RARE

Get notified when any member of Congress trades $RARE. Free, no card, no spam.

Follow free →
1
Disclosed trades
1
Buys
0
Sells
1
Members trading

The record on $RARE

Coldpine has parsed 1 disclosed trade in $RARE by 1 member of Congress, drawn from 1 periodic transaction report dated Jul 15, 2025. It came from the House, filed by a Democrat.

The one trade with a known filing lag was reported 30 days after the trade date, inside the 45-day window the STOCK Act sets: a $RARE purchase by Gilbert Cisneros dated Jul 15, 2025, disclosed Aug 14, 2025. How late filing is measured across all of Congress is in the late-filers study.

Members who trade RARE

Recent disclosed trades in RARE

DateMemberTypeAmount
Jul 15Gilbert Cisneros(CA)buy$1K–$15K

Data sourced from public STOCK Act disclosures. Coldpine is a publisher of intelligence on congressional disclosures, not an investment adviser. See full history and scores, free with an account →